AVENE XERA CALM A.D RELIPIDANT BALM 200ML
search
  • AVENE XERA CALM A.D RELIPIDANT BALM 200ML

AVENE XERACALM A.D CREME RELIPIDANTE 200ML


€15.90

Description

Nourishing - Anti-irritant
Soothes my itching sensations
Infants, children, adults
Severe dryness
Skin with atopic tendency
Sterile cosmetics

48 hours
Qty
In stock

100% secure payments

The Avène Dermatological Laboratories have developed the xeraCalm ADrelipidant cream, specially formulated for very dry skin with atopic tendency and prone to itching.

This cream nourishes and repairs the epidermis. It is an emollient care composed of the I-Modulia patent with anti-inflammatory, anti-itching and antimicrobial properties

It also contains Avène thermal spring water, with anti-inflammatory, anti-irritating and soothing properties, as well as Cer-Omega, a complex of ceramides and omega-6, which restores the protective hydrolipidic film.

After one month of application, itching and skin dryness are reduced by 97%. This treatment is the ideal relay to dermocortocoïd treatments

Please note: This treatment is a sterile cosmetic:

  • its formula is sterilized at a very high temperature and developed without preservatives or perfume,
  • its packaging allows to keep the formula safe from any bacterial contamination.

Indications:

Anti-itching cream:
  • for face and body ;
  • for dry, atopy-prone skin, prone to irritation and itching due to dry skin;
  • for infants, children and adults

Directions for use:

  • Squeeze the tube and apply the desired amount of cream once or twice a day to the dry areas of the face and/or body.
  • After use, remove the excess product and close the tube.

Composition:

Avene thermale spring water (avene aqua). glycerin. mineral oil (paraffinum liquidum). cetearyl alcohol. oenothera biennis (evening primrose) oil (oenothera biennis oil). caprylic/capric triglyceride. ceteraryl glucoside. aquaphilus dolomiae extract. arginine. carbomer. evening primrose oil
3282779405553

Specific References

chat Comments (0)
No customer reviews for the moment.